Morphic Medical, Inc.
GIDYL
OTC PK
| 03/31/2021 | 12/31/2020 | 09/30/2020 | 06/30/2020 | 03/31/2020 | |
|---|---|---|---|---|---|
| Net Income | -2.37M | -1.83M | -3.64M | -2.83M | -2.84M |
| Total Depreciation and Amortization | 43.00K | 6.00K | 7.00K | 7.00K | 42.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 323.00K | 447.00K | 1.35M | 535.00K | 484.00K |
| Change in Net Operating Assets | 263.00K | 268.00K | -152.00K | -1.78M | -927.00K |
| Cash from Operations | -1.74M | -1.11M | -2.43M | -4.07M | -3.24M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -123.00K | 623.00K | 945.00K | 4.60M |
| Total Debt Repaid | -41.00K | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 1.55M | 0.00 | 3.75M | -- | -- |
| Repurchase of Preferred Stock | -- | -286.00K | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.51M | -409.00K | 4.37M | 945.00K | 4.60M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -228.00K | -1.52M | 1.94M | -3.12M | 1.36M |
